This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard K. Forster, MD

Arch Ophthalmol. 1995;113(12):1555-1557.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE MANAGEMENT of endophthalmitis has gained increasing interest during the past two decades, particularly as a complication of cataract surgery, glaucoma filtering surgery, and penetrating ocular trauma. The use of intraocular antibiotics by intravitreal injection has now been widely accepted, with some questions as to the selection of the particular antibiotics. On the other hand, the role of therapeutic pars plana vitrectomy in the initial management of endophthalmitis and the benefit of systemic antibiotic therapy remain controversial. In this issue, the Endophthalmitis Vitrectomy Study (EVS) Group reports the results of a randomized trial of immediate pars plana vitrectomy and systemic antibiotics for the treatment of postoperative bacterial endophthalmitis.¹

Despite being controversial, an increasing proportion of patients with endophthalmitis undergo therapeutic vitrectomy as part of the initial management.² Experimental studies were prompted by the theoretical advantages offered by the technique of vitrectomy, including the removal and reduction of infecting . . . [Full Text PDF of this Article]

Author Affiliations
Miami, Fla

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?